Laboratory News and Research

RSS

Cannabidiol oils are equally or less effective at inhibiting certain cancer cell lines

Cannabidiol (CBD) oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, according to Penn State College of Medicine researchers.

18 Nov 2020

Children in Melbourne family developed COVID-19 immune response after exposure to virus

Children in a Melbourne family developed a COVID-19 immune response after chronic exposure to the SARS-CoV-2 virus from their parents, a new case report has found.

18 Nov 2020

Certain regions in the retina are more affected by Alzheimer's disease, shows study

A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina - the lining found in the back of the eye - that are more affected by Alzheimer's disease than other areas.

18 Nov 2020

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.

18 Nov 2020

SARS-CoV-2 was circulating in Italy before China recognized its existence

This study, published in the Tumori Journal, sheds light on the possibility that the virus had been spreading in Italy well before the outbreak was officially reported in Wuhan, China.

17 Nov 2020

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in scleroderma, a connective tissue disorder.

17 Nov 2020

New multiplex assay can be used for epidemiological surveillance, management of COVID-19

Scientists from Northwell Health Laboratories have developed a new diagnostic multiplex assay that can be used for epidemiological surveillance and clinical management of COVID-19.

17 Nov 2020

New AHA COVID-19 CVD Registry details the disparities in care

A new American Heart Association collaborative model for COVID-19 research, using data from the new AHA COVID-19 Cardiovascular Disease Registry, found Hispanic and Black adults with COVID-19 were far more likely to be hospitalized than their white counterparts, as were people with obesity and COVID-19, according to three late-breaking research studies presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

ECG abnormalities can predict COVID-19 mortality

A team of scientists from New York University Langone Medical Center, USA, has revealed that the clinical severity of hospitalized patients with coronavirus disease 2019 (COVID-19) can be predicted by analyzing the level of troponin elevation and electrocardiographic (ECG) abnormalities. The study is currently available on the medRxiv preprint server.

17 Nov 2020

Novel protein imaging method could lead to the development of new biomaterials

Scientists have established a new method to image proteins that could lead to new discoveries in disease through biological tissue and cell analysis and the development of new biomaterials that can be used for the next generation of drug delivery systems and medical devices.

17 Nov 2020

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

Researchers from the Huazhong University of Science and Technology and Shanghai Jiao Tong University, China, recently built a proteome microarray with 20 out of the 28 predicted SARS-CoV-2 proteins to help understand IgM/IgG responses specific to SARS-CoV-2.

17 Nov 2020

Researchers report encouraging results from in vitro combination therapy against COVID-19

Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19.

17 Nov 2020

Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2

Experiments led by researchers at the Department of Energy's Oak Ridge National Laboratory have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.

17 Nov 2020

Cynical hostility poses the greatest risk for cardiovascular disease

Cynical hostility is a potential pathway to cardiovascular disease by preventing a healthy response to stress over time, according to a study led by Baylor University.

17 Nov 2020

Researchers identify anti-inflammatory mechanisms that drive alcohol addiction

Deep within the brain, a small almond-shaped region called the amygdala plays a vital role in how we exhibit emotion, behavior, and motivation.

17 Nov 2020

Aarhus University to open new engineering and neuroscience research center

A new cross-disciplinary center will develop brain-machine interface technologies. One of the goals is to develop the next generation of technology to monitor, diagnose, and treat brain diseases while at the same time developing brand new brain-inspired AI hardware.

17 Nov 2020

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Short bursts of physical exercise induce changes in the body's levels of metabolites that correlate to, and may help gauge, an individual's cardiometabolic, cardiovascular and long-term health, a study by Massachusetts General Hospital has found.

16 Nov 2020

UCLA Health collaborates with Regeneron Genetics Center to bring genomic medicine to patients

UCLA Health has entered into a collaborative research agreement with the Regeneron Genetics Center (RGC) to provide whole exome sequencing for 150,000 UCLA Health patients.

16 Nov 2020

Researchers identify key source of signals encoding past experiences in the brain

Researchers identify a region of the brain as a key source of signals encoding past experiences in the neocortex.

16 Nov 2020

Antibiotics administered before age 2 are linked to ongoing conditions

In a retrospective case study, Mayo Clinic researchers have found that antibiotics administered to children younger than 2 are associated with several ongoing illnesses or conditions, ranging from allergies to obesity. The findings appear in Mayo Clinic Proceedings.

16 Nov 2020

Laboratory News and Research

Cannabidiol oils are equally or less effective at inhibiting certain cancer cell lines

Children in Melbourne family developed COVID-19 immune response after exposure to virus

Certain regions in the retina are more affected by Alzheimer's disease, shows study

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

SARS-CoV-2 was circulating in Italy before China recognized its existence

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

New multiplex assay can be used for epidemiological surveillance, management of COVID-19

New AHA COVID-19 CVD Registry details the disparities in care

ECG abnormalities can predict COVID-19 mortality

Novel protein imaging method could lead to the development of new biomaterials

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

Researchers report encouraging results from in vitro combination therapy against COVID-19

Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2

Cynical hostility poses the greatest risk for cardiovascular disease

Researchers identify anti-inflammatory mechanisms that drive alcohol addiction

Aarhus University to open new engineering and neuroscience research center

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

UCLA Health collaborates with Regeneron Genetics Center to bring genomic medicine to patients

Researchers identify key source of signals encoding past experiences in the brain

Antibiotics administered before age 2 are linked to ongoing conditions

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo